| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Grifols S.A (NASDAQ: GRFS)
GRFS Technical Analysis
4
| As on 9th Jun 2023 GRFS SHARE Price closed @ 8.83 and we RECOMMEND Sell for LONG-TERM with Stoploss of 10.12 & Strong Sell for SHORT-TERM with Stoploss of 11.60 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GRFSSHARE Price
| Open | 8.77 | Change | Price | % |
| High | 8.83 | 1 Day | 0.03 | 0.34 |
| Low | 8.67 | 1 Week | 0.59 | 7.16 |
| Close | 8.83 | 1 Month | 1.47 | 19.97 |
| Volume | 398300 | 1 Year | -2.14 | -19.51 |
| 52 Week High 13.28 | 52 Week Low 5.95 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| GRFS Daily Charts |
GRFS Intraday Charts |
Whats New @ Bazaartrend |
GRFS Free Analysis |
|
|
GRFS Important Levels Intraday
| RESISTANCE | 9.14 |
| RESISTANCE | 9.04 |
| RESISTANCE | 8.98 |
| RESISTANCE | 8.92 |
| SUPPORT | 8.74 |
| SUPPORT | 8.68 |
| SUPPORT | 8.62 |
| SUPPORT | 8.52 |
GRFS Forecast April 2024
| 4th UP Forecast | 12.7 |
| 3rd UP Forecast | 11.46 |
| 2nd UP Forecast | 10.69 |
| 1st UP Forecast | 9.93 |
| 1st DOWN Forecast | 7.73 |
| 2nd DOWN Forecast | 6.97 |
| 3rd DOWN Forecast | 6.2 |
| 4th DOWN Forecast | 4.96 |
GRFS Weekly Forecast
| 4th UP Forecast | 10.01 |
| 3rd UP Forecast | 9.63 |
| 2nd UP Forecast | 9.40 |
| 1st UP Forecast | 9.16 |
| 1st DOWN Forecast | 8.50 |
| 2nd DOWN Forecast | 8.26 |
| 3rd DOWN Forecast | 8.03 |
| 4th DOWN Forecast | 7.65 |
GRFS Forecast2024
| 4th UP Forecast | 23.53 |
| 3rd UP Forecast | 18.82 |
| 2nd UP Forecast | 15.9 |
| 1st UP Forecast | 12.99 |
| 1st DOWN Forecast | 4.67 |
| 2nd DOWN Forecast | 1.76 |
| 3rd DOWN Forecast | -1.16 |
| 4th DOWN Forecast | -5.87 |
Grifols S.A ( NASDAQ USA Symbol : GRFS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GRFS Business Profile
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others segments. The Bioscience segment produces plasma-derived medicines for the treatment of rare, chronic, and life-threatening conditions. It offers intravenous immunoglobin, albumin, alpha-1-antitrypsin, factor VIII, antithrombin, and other specialty hyperimmune immunoglobulins. The Hospital segment offers non-biological pharmaceutical products and medical supplies for hospital pharmacy, such as intravenous solutions, pharmatech solutions, clinical nutrition products, and medical devices for interventional therapy. The Diagnostic segment manufactures and markets diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment provides biological products for non-therapeutic uses. The Others segment renders manufacturing services to third party companies. The company also provides engineering services; and rents industrial buildings. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain. Address: Avinguda de la Generalitat, 152, Barcelona, Spain, 08174
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service